{
  "segment": [
    {
      "FY": "FY14",
      "period": "2015/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "タカラバイオグループ",
      "sales": 25144,
      "profit": 2302,
      "assets": 66425
    },
    {
      "FY": "FY14",
      "period": "2015/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "宝ヘルスケア",
      "sales": 1650,
      "profit": 38,
      "assets": 617
    },
    {
      "FY": "FY14",
      "period": "2015/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "宝酒造グループ",
      "sales": 189760,
      "profit": 7840,
      "assets": 151523
    },
    {
      "FY": "FY15",
      "period": "2016/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "タカラバイオグループ",
      "sales": 28818,
      "profit": 2667,
      "assets": 66591
    },
    {
      "FY": "FY15",
      "period": "2016/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "宝ヘルスケア",
      "sales": 1863,
      "profit": 64,
      "assets": 712
    },
    {
      "FY": "FY15",
      "period": "2016/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "宝酒造グループ",
      "sales": 191736,
      "profit": 8410,
      "assets": 150773
    },
    {
      "FY": "FY16",
      "period": "2017/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "タカラバイオグループ",
      "sales": 28529,
      "profit": 3202,
      "assets": 67143
    },
    {
      "FY": "FY16",
      "period": "2017/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "宝酒造",
      "sales": 149408,
      "profit": 5071,
      "assets": 90931
    },
    {
      "FY": "FY16",
      "period": "2017/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "宝酒造インターナショナルグループ",
      "sales": 37278,
      "profit": 3182,
      "assets": 64759
    },
    {
      "FY": "FY17",
      "period": "2018/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "タカラバイオグループ",
      "sales": 31617,
      "profit": 3555,
      "assets": 68670
    },
    {
      "FY": "FY17",
      "period": "2018/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "宝酒造",
      "sales": 149426,
      "profit": 5569,
      "assets": 95131
    },
    {
      "FY": "FY17",
      "period": "2018/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "宝酒造インターナショナルグループ",
      "sales": 70456,
      "profit": 4393,
      "assets": 68103
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "タカラバイオグループ",
      "sales": 35432,
      "profit": 5463,
      "assets": 71040
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "宝酒造",
      "sales": 151805,
      "profit": 5948,
      "assets": 92682
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "宝酒造インターナショナルグループ",
      "sales": 77573,
      "profit": 4532,
      "assets": 68003
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "タカラバイオグループ",
      "sales": 34563,
      "profit": 6274,
      "assets": 75009
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "宝酒造",
      "sales": 152496,
      "profit": 4175,
      "assets": 93083
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "宝酒造インターナショナルグループ",
      "sales": 82456,
      "profit": 3532,
      "assets": 75183
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "タカラバイオグループ",
      "sales": 46086,
      "profit": 13952,
      "assets": 89750
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "宝酒造",
      "sales": 151972,
      "profit": 4879,
      "assets": 90221
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "宝酒造インターナショナルグループ",
      "sales": 69348,
      "profit": 1043,
      "assets": 74373
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "タカラバイオグループ",
      "sales": 67699,
      "profit": 28902,
      "assets": 115712
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "宝酒造",
      "sales": 118889,
      "profit": 4135,
      "assets": 90442
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "宝酒造インターナショナルグループ",
      "sales": 101920,
      "profit": 8472,
      "assets": 89836
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "タカラバイオグループ",
      "sales": 78139,
      "profit": 20541,
      "assets": 129202
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "宝酒造",
      "sales": 122116,
      "profit": 4890,
      "assets": 89979
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "宝酒造インターナショナルグループ",
      "sales": 137256,
      "profit": 10821,
      "assets": 121348
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "タカラバイオグループ",
      "sales": 43504,
      "profit": 3003,
      "assets": 121252
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "宝酒造",
      "sales": 122964,
      "profit": 5503,
      "assets": 92722
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "宝酒造インターナショナルグループ",
      "sales": 160082,
      "profit": 12291,
      "assets": 147078
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "タカラバイオグループ",
      "sales": 45038,
      "profit": 2263,
      "assets": 125334
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "宝酒造",
      "sales": 118774,
      "profit": 5037,
      "assets": 88037
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "宝酒造インターナショナルグループ",
      "sales": 185434,
      "profit": 11655,
      "assets": 200324
    }
  ]
}